Clinical Trial Update: A Study of Daridorexant in Chinese Patients With Insomnia Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating daridorexant for insomnia disorder in Chinese patients has completed. The document notes the study status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Daridorexant (daridorexant)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Insomnia Disorder | Phase 3 | Status: COMPLETED